Daxa M. Patel

Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.

J. Markert, P. Foreman, G. Gillespie, 2016, Human gene therapy. Clinical development.